These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 22085227)

  • 1. Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie's disease and erectile dysfunction: results from a prospective randomized trial.
    Palmieri A; Imbimbo C; Creta M; Verze P; Fusco F; Mirone V
    Int J Androl; 2012 Apr; 35(2):190-5. PubMed ID: 22085227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal shockwave therapy for Peyronie's disease: an alternative treatment?
    Poulakis V; Skriapas K; de Vries R; Dillenburg W; Ferakis N; Witzsch U; Melekos M; Becht E
    Asian J Androl; 2006 May; 8(3):361-6. PubMed ID: 16625288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie's disease: a double-blind, placebo-controlled randomized study.
    Safarinejad MR
    Int J Impot Res; 2010; 22(5):298-309. PubMed ID: 20720560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shockwave Therapy in the Treatment of Peyronie's Disease.
    Krieger JR; Rizk PJ; Kohn TP; Pastuszak A
    Sex Med Rev; 2019 Jul; 7(3):499-507. PubMed ID: 30926460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie's disease, erectile dysfunction and chronic pelvic pain.
    Fojecki GL; Tiessen S; Osther PJ
    World J Urol; 2017 Jan; 35(1):1-9. PubMed ID: 27108421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal shockwave therapy in the treatment of erectile dysfunction: a prospective, randomized, double-blinded, placebo controlled study.
    Yee CH; Chan ES; Hou SS; Ng CF
    Int J Urol; 2014 Oct; 21(10):1041-5. PubMed ID: 24942563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Questionable efficacy of extracorporeal shock wave therapy for Peyronie's disease: results of a prospective approach.
    Hauck EW; Hauptmann A; Bschleipfer T; Schmelz HU; Altinkilic BM; Weidner W
    J Urol; 2004 Jan; 171(1):296-9. PubMed ID: 14665898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Peyronie's disease--a review.
    Tunuguntla HS
    World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease.
    Palmieri A; Imbimbo C; Longo N; Fusco F; Verze P; Mangiapia F; Creta M; Mirone V
    Eur Urol; 2009 Aug; 56(2):363-9. PubMed ID: 19473751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of a Novel Penile Traction Device in Men with Peyronie's Disease: A Randomized, Single-Blind, Controlled Trial.
    Ziegelmann M; Savage J; Toussi A; Alom M; Yang D; Kohler T; Trost L
    J Urol; 2019 Sep; 202(3):599-610. PubMed ID: 30916626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal shock wave therapy in Peyronie's disease: results of a placebo-controlled, prospective, randomized, single-blind study.
    Hatzichristodoulou G; Meisner C; Gschwend JE; Stenzl A; Lahme S
    J Sex Med; 2013 Nov; 10(11):2815-21. PubMed ID: 23898925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited shock wave therapy vs sham treatment in men with Peyronie's disease: results of a prospective randomized controlled double-blind trial.
    Chitale S; Morsey M; Swift L; Sethia K
    BJU Int; 2010 Nov; 106(9):1352-6. PubMed ID: 20438568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Extracorporeal shockwave therapy for erectile dysfunction and Peyronie's disease].
    Zhu JY; Jiang R
    Zhonghua Nan Ke Xue; 2014 Sep; 20(9):846-9. PubMed ID: 25306816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focused extracorporeal shockwave therapy in Dupuytren's disease--a hypothesis.
    Knobloch K; Kuehn M; Vogt PM
    Med Hypotheses; 2011 May; 76(5):635-7. PubMed ID: 21277691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of loss of penile rigidity associated with Peyronie's disease.
    Krane RJ
    Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
    Skoumal R; Chen J; Kula K; Breza J; Calomfirescu N; Basson BR; Kopernicky V
    Eur Urol; 2004 Sep; 46(3):362-9; discussion 369. PubMed ID: 15306109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men.
    Guo YL; Zhu JC; Pan TM; Ding Q; Wang YX; Cheong NF; Lim E; Shen W; Venugopalan M; Chan M
    Int J Urol; 2006 Jun; 13(6):721-7. PubMed ID: 16834650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of erectile dysfunction in patients with plastic induration of the penis].
    Sokol'shchik MM; Gagarina SV; Petrovich RIu; Sadakova IV
    Urologiia; 2008; (1):41-4. PubMed ID: 18649679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma.
    Incrocci L; Slagter C; Slob AK; Hop WC
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):439-44. PubMed ID: 16965992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of incision and saphenous vein grafting for Peyronie's disease on penile length and sexual satisfaction.
    Yurkanin JP; Dean R; Wessells H
    J Urol; 2001 Nov; 166(5):1769-72; discussion 1772-3. PubMed ID: 11586221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.